Immunovia AB is a medical laboratory based in Lund that specializes in the early detection of pancreatic cancer. The organization is known for its development of the PancreaSure test, which aims to provide high accuracy in diagnostics. This innovative approach is designed to improve survival rates by facilitating the identification of pancreatic cancer at earlier stages, which is critical for effective treatment.
The company emphasizes the importance of annual surveillance for individuals at risk of developing pancreatic cancer. Research indicates that early-stage diagnoses can significantly increase survival odds, making timely and accurate testing essential. Immunovia AB is committed to raising awareness about pancreatic cancer and advocates for the implementation of effective testing methods to enhance patient outcomes. Through its mission-driven efforts, the organization seeks to contribute to advancements in cancer diagnostics and ultimately save lives.